Biswajit Kundu

546 total citations
17 papers, 411 citations indexed

About

Biswajit Kundu is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Biswajit Kundu has authored 17 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 3 papers in Toxicology. Recurrent topics in Biswajit Kundu's work include Cancer therapeutics and mechanisms (5 papers), Synthesis and bioactivity of alkaloids (3 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Biswajit Kundu is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Synthesis and bioactivity of alkaloids (3 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Biswajit Kundu collaborates with scholars based in India, United States and United Kingdom. Biswajit Kundu's co-authors include Arindam Talukdar, Sourav Pal, Vinay Kumar, Mohabul A. Mondal, Malliga R. Iyer, Benu Brata Das, Subhendu Das, Arijit Ghosh, Deblina Raychaudhuri and Dipyaman Ganguly and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and RSC Advances.

In The Last Decade

Biswajit Kundu

17 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biswajit Kundu India 10 224 151 96 60 43 17 411
Shagun Krishna India 15 256 1.1× 144 1.0× 96 1.0× 44 0.7× 32 0.7× 28 478
Syed Hussain Basha India 10 150 0.7× 78 0.5× 75 0.8× 71 1.2× 15 0.3× 32 370
Yaser A. Mostafa Egypt 16 265 1.2× 336 2.2× 56 0.6× 91 1.5× 34 0.8× 41 618
Manoj Kumar Mahapatra India 10 144 0.6× 171 1.1× 98 1.0× 33 0.6× 26 0.6× 16 368
Daniel J. Mason United Kingdom 11 313 1.4× 140 0.9× 152 1.6× 51 0.8× 19 0.4× 14 513
Gihwan Lee South Korea 15 273 1.2× 93 0.6× 159 1.7× 52 0.9× 11 0.3× 39 497
Siddharth Manvati India 12 326 1.5× 98 0.6× 21 0.2× 44 0.7× 26 0.6× 15 583
Hafiz Muzzammel Rehman Pakistan 13 198 0.9× 111 0.7× 106 1.1× 37 0.6× 17 0.4× 62 480
Himanshu Verma India 14 213 1.0× 133 0.9× 64 0.7× 69 1.1× 12 0.3× 44 552
Aäron C. Beekman Netherlands 9 230 1.0× 118 0.8× 49 0.5× 45 0.8× 21 0.5× 9 483

Countries citing papers authored by Biswajit Kundu

Since Specialization
Citations

This map shows the geographic impact of Biswajit Kundu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biswajit Kundu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biswajit Kundu more than expected).

Fields of papers citing papers by Biswajit Kundu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biswajit Kundu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biswajit Kundu. The network helps show where Biswajit Kundu may publish in the future.

Co-authorship network of co-authors of Biswajit Kundu

This figure shows the co-authorship network connecting the top 25 collaborators of Biswajit Kundu. A scholar is included among the top collaborators of Biswajit Kundu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biswajit Kundu. Biswajit Kundu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dvorácskó, Szabolcs, Biswajit Kundu, Henry L. Puhl, et al.. (2025). Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders. Metabolism. 170. 156291–156291. 1 indexed citations
2.
Kundu, Biswajit, Szabolcs Dvorácskó, Abhishek Basu, et al.. (2024). Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors. Molecules. 29(13). 3036–3036. 2 indexed citations
3.
Kundu, Biswajit & Malliga R. Iyer. (2023). A patent review on aldehyde dehydrogenase inhibitors: an overview of small molecule inhibitors from the last decade. Expert Opinion on Therapeutic Patents. 33(10). 651–668. 3 indexed citations
4.
Talukdar, Arindam, et al.. (2022). Topoisomerase I inhibitors: Challenges, progress and the road ahead. European Journal of Medicinal Chemistry. 236. 114304–114304. 60 indexed citations
5.
Iyer, Malliga R., et al.. (2022). One-Pot Synthesis of Thio-Augmented Sulfonylureas via a Modified Bunte’s Reaction. ACS Omega. 7(35). 31612–31620. 3 indexed citations
6.
Iyer, Malliga R., et al.. (2022). Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade. Expert Opinion on Therapeutic Patents. 32(6). 629–647. 20 indexed citations
7.
Kundu, Biswajit, Deblina Raychaudhuri, Purbita Bandopadhyay, et al.. (2021). Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9. Journal of Medicinal Chemistry. 64(13). 9279–9301. 19 indexed citations
8.
Kundu, Biswajit, et al.. (2020). Development of a metabolically stable topoisomerase I poison as anticancer agent. European Journal of Medicinal Chemistry. 202. 112551–112551. 10 indexed citations
9.
Raychaudhuri, Deblina, et al.. (2020). A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist. Journal of Medicinal Chemistry. 63(9). 4776–4789. 21 indexed citations
10.
Pal, Sourav, et al.. (2019). Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors. Computational and Structural Biotechnology Journal. 17. 291–310. 138 indexed citations
11.
Kundu, Biswajit, et al.. (2019). Understanding the riboflavin biosynthesis pathway for the development of antimicrobial agents. Medicinal Research Reviews. 39(4). 1338–1371. 16 indexed citations
12.
Mishra, Snehasis, et al.. (2019). Semisynthetic Quercetin Derivatives with Potent Antitumor Activity in Colon Carcinoma. ACS Omega. 4(4). 7285–7298. 27 indexed citations
13.
Kundu, Biswajit, Subhendu Das, Sourav Pal, et al.. (2019). Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity. Journal of Medicinal Chemistry. 62(7). 3428–3446. 59 indexed citations
14.
Kundu, Biswajit, et al.. (2017). Copper-catalyzed selective C–N bond formation with 2-amino, 2-hydroxy and 2-bromo-5-halopyridine. RSC Advances. 7(70). 44366–44370. 3 indexed citations
15.
Kundu, Biswajit, et al.. (2006). Pictet-Spengler Synthesis of Thiazolo- and Pyrazolo-quinolines. Synfacts. 2006(6). 552–552. 2 indexed citations
16.
Roy, Anup, et al.. (2002). F. N. A. C. of salivary glands. Indian Journal of Otolaryngology and Head & Neck Surgery. 54(3). 184–188. 2 indexed citations
17.
Tripathi, Rama P., Suchita Rastogi, Biswajit Kundu, et al.. (2001). Identification of Inhibitors of DNA Topoisomerase II from a Synthetic Library of Glycoconjugates. Combinatorial Chemistry & High Throughput Screening. 4(3). 237–234. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shagun Krishna Breakdown of academic impact, for papers by Syed Hussain Basha Breakdown of academic impact, for papers by Yaser A. Mostafa Breakdown of academic impact, for papers by Manoj Kumar Mahapatra Breakdown of academic impact, for papers by Daniel J. Mason Breakdown of academic impact, for papers by Gihwan Lee Breakdown of academic impact, for papers by Siddharth Manvati Breakdown of academic impact, for papers by Hafiz Muzzammel Rehman Breakdown of academic impact, for papers by Himanshu Verma Breakdown of academic impact, for papers by Aäron C. Beekman
Rankless by CCL
2026